Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study.

Autor: Varbanova, Viktoria Plamenova1 viktoriia1982@abv.bg, Mihailova, Snejina2, Naumova, Elissaveta2, Mihaylova, Anastasiya Petrova2
Zdroj: Turkish Journal of Hematology. 2019, Vol. 36 Issue 4, p238-246. 9p.
Databáze: Academic Search Ultimate